Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors

Clinical trial NCT01428427 · COMPLETED

Trial details

NCT number: NCT01428427
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukaemia, Myelocytic, Acute

Start date: 2009-08-12
Primary completion: 2011-07-18
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.